8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Whole Body / General209 citations

Kim JH, Chung KH, Hwang YR, Park HR, Kim HJ, Kim HG, Kim HR

Bioeffects Seen

Authors not listed · 2021

Share:

Healthcare system disruptions during COVID-19 prevented 15% of cancer patients from receiving planned surgery during full lockdowns.

Plain English Summary

Summary written for general audiences

This international study tracked 20,006 cancer patients across 61 countries during COVID-19 to examine how lockdown restrictions affected cancer surgery delivery. Researchers found that stricter lockdowns dramatically increased surgery cancellations - from 0.6% under light restrictions to 15% during full lockdowns. The findings reveal how healthcare system disruptions can compound health risks beyond the immediate crisis.

Why This Matters

While this study doesn't directly examine EMF health effects, it provides a crucial lesson about healthcare system resilience that applies to EMF research advocacy. Just as COVID-19 lockdowns created a secondary health crisis by disrupting cancer care, the telecommunications industry's influence on regulatory agencies creates barriers to addressing EMF health risks. The study shows how one in seven cancer patients lost access to potentially life-saving surgery during full lockdowns - a stark reminder that institutional failures can amplify health threats. This parallels how regulatory capture in EMF policy leaves the public vulnerable to radiation exposure while independent research struggles for recognition and funding.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2021). Kim JH, Chung KH, Hwang YR, Park HR, Kim HJ, Kim HG, Kim HR.
Show BibTeX
@article{kim_jh_chung_kh_hwang_yr_park_hr_kim_hj_kim_hg_kim_hr_ce3309,
  author = {Unknown},
  title = {Kim JH, Chung KH, Hwang YR, Park HR, Kim HJ, Kim HG, Kim HR},
  year = {2021},
  doi = {10.1016/S1470-2045(21)00493-9},
  
}
DOI: 10.1016/S1470-2045(21)00493-9PubMed: 34624250

Quick Questions About This Study

Of 20,006 cancer patients studied, 2,003 patients (10%) did not receive their planned surgery. The rate varied dramatically by lockdown severity - only 0.6% missed surgery under light restrictions versus 15% during full lockdowns.
The study included 466 hospitals across 61 countries worldwide, making it one of the largest international assessments of healthcare disruption during the COVID-19 pandemic. Specific countries weren't listed in the available abstract.
Short-term cancer outcomes weren't compromised for patients who eventually received surgery, even with delays. However, researchers warn that delays and missed operations could lead to reduced long-term survival rates for affected patients.
Surgery delays beyond 12 weeks increased significantly during lockdowns. Under light restrictions, 9.1% waited over 12 weeks, compared to 23.8% during full lockdowns. Median follow-up was 23 weeks across all patients.
The study examined 15 different cancer types requiring curative surgery. All patients were adults (18+ years) who had surgical decisions made during the pandemic and were followed until surgery or study end.